Frezyderm AC-NORM Medilike Effect 3 Cream 50ml

Frezyderm AC-NORM Medilike Effect 3 Cream 50ml | Targeted Medical Device Cream for Severe Inflammatory Acne

Frezyderm AC-NORM Medilike Effect 3 Cream 50ml is a specialised topical medical device developed for skin affected by severe inflammatory nodulocystic acne. Designed for targeted application to affected areas, the formula uses a controlled-release system to support the management of acne lesions, including comedones, papules and pustules.

Severe inflammatory acne can involve deep, uncomfortable lesions and persistent breakouts that require careful assessment and appropriate management. Frezyderm AC-NORM Medilike Effect 3 is specifically positioned for Type 3 acne, offering a topical medical-device approach that differs from conventional pharmaceutical acne treatments.

The formulation features slow-release salicylic acid, which provides a controlled keratolytic action. This helps address the build-up of dead skin cells associated with blocked pores and acne lesions. Its specialised film-forming system allows gradual release of active ingredients through a mechanism described by Frezyderm as sebaceous absorption.

Unlike general-purpose skincare products for occasional blemishes, Medilike Effect 3 is intended for severe inflammatory acne. It belongs to the Frezyderm AC-NORM collection, which focuses on the needs of oily and acne-prone skin, including concerns such as enlarged-looking pores and inflammatory breakouts.

The product is described by the manufacturer as a medical-device option that may be used independently or alongside prescribed acne treatments when appropriate. However, severe nodulocystic acne can cause permanent scarring and requires medical assessment. This cream should not be considered an automatic replacement for prescription treatment.

Frezyderm AC-NORM Medilike Effect 3 is applied directly to affected skin areas rather than used as a general facial moisturiser. The recommended application frequency is one to two times daily, depending on the individual case, for a maximum period of 30 days.

Dermatologically tested, the cream is intended for external use only. It must be kept away from the eyes and mucous membranes and stored between 15°C and 25°C.

For safe and appropriate use, follow the medical-device instructions supplied with the product and seek guidance from a dermatologist, doctor or pharmacist, particularly when managing severe acne or combining the cream with other treatments.

Key Features

• Topical medical device specifically intended for severe inflammatory nodulocystic acne

• Developed for Type 3 acne rather than occasional spots or mild blemishes

• Contains slow-release salicylic acid for controlled keratolytic action

• Uses a specialised film-forming system for gradual ingredient release

• Dermatologically tested, with a manufacturer-stated treatment period of up to 30 days

Key Benefits

• Provides targeted topical care for severe inflammatory acne lesions

• Helps address comedones through the keratolytic action of salicylic acid

• Offers controlled release of active ingredients to affected skin areas

• Supports the management of acne-prone skin as directed by the manufacturer

• May complement clinician-directed acne treatment when its use is considered appropriate

Key Ingredients

Slow-Release Salicylic Acid: A keratolytic ingredient designed to help loosen accumulated dead skin cells and address blocked pores and acne lesions.

Specialised Film-Forming System: A delivery mechanism described by the manufacturer as supporting the gradual release of active ingredients through sebaceous absorption.

Additional Formulation Information: The supplied information does not include the complete INCI ingredient list or salicylic acid concentration. These details should be confirmed against the product packaging and medical-device instructions.

How to Use

Apply Frezyderm AC-NORM Medilike Effect 3 Cream directly to affected skin areas according to the manufacturer's instructions.

• Frequency: One to two applications daily, depending on the individual case.

• Duration: Use for up to 30 days, unless a healthcare professional provides different instructions.

• Application area: Affected skin only.

• External use only: Avoid contact with the eyes and mucous membranes.

• Storage: Store between 15°C and 25°C, away from children.

Important: Severe nodulocystic acne should be assessed by a healthcare professional because of the risk of scarring. Do not discontinue prescribed acne medication or combine treatments without appropriate medical advice.

Formulated Without / Formulation Information

• Classified as a medical device

• Contains slow-release salicylic acid

• Uses a controlled-release film-forming system

• Dermatologically tested

• Intended for a defined course of use rather than unrestricted long-term application

The manufacturer's description positions this product as an alternative approach to certain pharmaceutical acne treatments. However, this does not mean that it is free from all pharmacologically active ingredients or that it can replace prescribed treatment.

No additional fragrance-free, alcohol-free, paraben-free or other ingredient-exclusion claims have been confirmed.